Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1188306

Cover Image

PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1188306

Biodefense Market Research Report by Product (Anthrax, Botulism, and Radiation), End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, High Inflation - Global Forecast 2023-2030

PUBLISHED:
PAGES: 249 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access - 1 Year (Single User License)
USD 3949
PDF & Excel + Online Access - 1 Year (Single User License)
USD 4949
PDF & Excel + Online Access - 1 Year (Up to 5 User License)
USD 5949
PDF & Excel + Online Access - 1 Year (Site License)
USD 6949
PDF & Excel + Online Access - 1 Year (Enterprise User License)
USD 8949

Add to Cart

Contact us about how to customize the report with add-on data.

The Global Biodefense Market size was estimated at USD 16.58 billion in 2022 and expected to reach USD 18.36 billion in 2023, projecting growth at a CAGR of 11.18% to reach USD 38.73 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Biodefense Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Biodefense Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Biodefense Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Biodefense Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global Biodefense Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.

Based on Product, the market is studied across Anthrax, Botulism, Radiation, and Small Pox.

Based on End-User, the market is studied across Ambulatory Care Centers, Hospitals, Military, and Research Organizations.

Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Biodefense Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Biodefense Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Biodefense Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Biodefense Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biodefense Market, including Alnylam Pharmaceuticals, Inc., Altimmune, Inc., Bavarian Nordic A/S, BDO USA, LLP, Bharat Biotech Ltd., Dynport Vaccine Company by General Dynamics Information Technology, Elusys Therapeutics, Inc. by Heat Biologics Inc., Emergent BioSolutions Inc., Evogen, Inc., Ichor Medical Systems, Inc., Pizer Inc., Serum Institute of India Pvt. Ltd., SIGA Technologies, Soligenix, Inc., and Xoma Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biodefense Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biodefense Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biodefense Market?

4. What is the competitive strategic window for opportunities in the Global Biodefense Market?

5. What are the technology trends and regulatory frameworks in the Global Biodefense Market?

6. What is the market share of the leading vendors in the Global Biodefense Market?

7. What modes and strategic moves are considered suitable for entering the Global Biodefense Market?

Product Code: MRR-434CCDA050D6

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Presence of favorable government initiatives
      • 5.1.1.2. Growing prevalence of various agents such as Ebola virus, Ziva virus, and others
      • 5.1.1.3. Increasing importance of disease surveillance
    • 5.1.2. Restraints
      • 5.1.2.1. Low market penetration in developing and underdeveloped countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising initiatives for research & developments in developed countries
      • 5.1.3.2. Technological advancement in biotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. High time investment and longer clinical procedures
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Cumulative Impact of Russia-Ukraine Conflict
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Threat of Substitutes
    • 5.5.4. Threat of Substitutes
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework
  • 5.8. Client Customization

6. Biodefense Market, by Product

  • 6.1. Introduction
  • 6.2. Anthrax
  • 6.3. Botulism
  • 6.4. Radiation
  • 6.5. Small Pox

7. Biodefense Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Care Centers
  • 7.3. Hospitals
  • 7.4. Military
  • 7.5. Research Organizations

8. Americas Biodefense Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biodefense Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biodefense Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis, By Key Player
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Product Portfolio Analysis, By Key Player
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Alnylam Pharmaceuticals, Inc.
  • 12.2. Altimmune, Inc.
  • 12.3. Bavarian Nordic A/S
  • 12.4. BDO USA, LLP
  • 12.5. Bharat Biotech Ltd.
  • 12.6. Dynport Vaccine Company by General Dynamics Information Technology
  • 12.7. Elusys Therapeutics, Inc. by Heat Biologics Inc.
  • 12.8. Emergent BioSolutions Inc.
  • 12.9. Evogen, Inc.
  • 12.10. Ichor Medical Systems, Inc.
  • 12.11. Pizer Inc.
  • 12.12. Serum Institute of India Pvt. Ltd.
  • 12.13. SIGA Technologies
  • 12.14. Soligenix, Inc.
  • 12.15. Xoma Corporation

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
Product Code: MRR-434CCDA050D6

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIODEFENSE MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIODEFENSE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. GLOBAL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIODEFENSE MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
  • FIGURE 7. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 8. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIODEFENSE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 10. GLOBAL BIODEFENSE MARKET DYNAMICS
  • FIGURE 11. GLOBAL BIODEFENSE MARKET PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 13. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIODEFENSE MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
  • FIGURE 15. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX, 2018-2030 (USD MILLION)
  • FIGURE 16. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM, 2018-2030 (USD MILLION)
  • FIGURE 17. GLOBAL BIODEFENSE MARKET SIZE, BY RADIATION, 2018-2030 (USD MILLION)
  • FIGURE 18. GLOBAL BIODEFENSE MARKET SIZE, BY SMALL POX, 2018-2030 (USD MILLION)
  • FIGURE 19. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 20. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. GLOBAL BIODEFENSE MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
  • FIGURE 22. GLOBAL BIODEFENSE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
  • FIGURE 23. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • FIGURE 24. GLOBAL BIODEFENSE MARKET SIZE, BY MILITARY, 2018-2030 (USD MILLION)
  • FIGURE 25. GLOBAL BIODEFENSE MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • FIGURE 26. AMERICAS BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 27. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 28. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 29. AMERICAS BIODEFENSE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 30. ARGENTINA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 31. BRAZIL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 32. CANADA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 33. MEXICO BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 34. UNITED STATES BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 35. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 36. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 37. UNITED STATES BIODEFENSE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
  • FIGURE 38. ASIA-PACIFIC BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 39. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 40. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 41. ASIA-PACIFIC BIODEFENSE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 42. AUSTRALIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 43. CHINA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 44. INDIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 45. INDONESIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 46. JAPAN BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 47. MALAYSIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 48. PHILIPPINES BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 49. SINGAPORE BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 50. SOUTH KOREA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 51. TAIWAN BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 52. THAILAND BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 53. VIETNAM BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 54. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 56. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 57. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 58. DENMARK BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 59. EGYPT BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 60. FINLAND BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 61. FRANCE BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 62. GERMANY BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 63. ISRAEL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 64. ITALY BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 65. NETHERLANDS BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 66. NIGERIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 67. NORWAY BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 68. POLAND BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 69. QATAR BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 70. RUSSIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 71. SAUDI ARABIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 72. SOUTH AFRICA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 73. SPAIN BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 74. SWEDEN BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 75. SWITZERLAND BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 76. TURKEY BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 77. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 78. UNITED KINGDOM BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 79. GLOBAL BIODEFENSE MARKET: FPNV POSITIONING MATRIX, 2022
  • FIGURE 80. GLOBAL BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 81. GLOBAL BIODEFENSE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

LIST OF TABLES

  • TABLE 1. GLOBAL BIODEFENSE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. GLOBAL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIODEFENSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIODEFENSE MARKET SIZE, BY ANTHRAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIODEFENSE MARKET SIZE, BY BOTULISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIODEFENSE MARKET SIZE, BY RADIATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIODEFENSE MARKET SIZE, BY RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIODEFENSE MARKET SIZE, BY RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIODEFENSE MARKET SIZE, BY SMALL POX, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIODEFENSE MARKET SIZE, BY SMALL POX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIODEFENSE MARKET SIZE, BY SMALL POX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIODEFENSE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIODEFENSE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIODEFENSE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIODEFENSE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIODEFENSE MARKET SIZE, BY MILITARY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIODEFENSE MARKET SIZE, BY MILITARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIODEFENSE MARKET SIZE, BY MILITARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIODEFENSE MARKET SIZE, BY RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIODEFENSE MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIODEFENSE MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BIODEFENSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SOUTH KOREA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. TAIWAN BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 84. TAIWAN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. THAILAND BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 87. THAILAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. THAILAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. VIETNAM BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 90. VIETNAM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. VIETNAM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. DENMARK BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 97. DENMARK BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. DENMARK BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. EGYPT BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 100. EGYPT BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EGYPT BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. FINLAND BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 103. FINLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. FINLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. FRANCE BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 106. FRANCE BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. FRANCE BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. GERMANY BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 109. GERMANY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. GERMANY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. ISRAEL BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 112. ISRAEL BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. ISRAEL BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. ITALY BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 115. ITALY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. ITALY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. NETHERLANDS BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 118. NETHERLANDS BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. NETHERLANDS BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. NIGERIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 121. NIGERIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. NIGERIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. NORWAY BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 124. NORWAY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. NORWAY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. POLAND BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 127. POLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. POLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. QATAR BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 130. QATAR BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. QATAR BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. RUSSIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 133. RUSSIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. RUSSIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SAUDI ARABIA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 136. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SAUDI ARABIA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH AFRICA BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH AFRICA BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. SPAIN BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 142. SPAIN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SPAIN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. SWEDEN BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 145. SWEDEN BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SWEDEN BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. SWITZERLAND BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 148. SWITZERLAND BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. SWITZERLAND BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. TURKEY BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 151. TURKEY BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. TURKEY BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED ARAB EMIRATES BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED KINGDOM BIODEFENSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. UNITED KINGDOM BIODEFENSE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. GLOBAL BIODEFENSE MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
  • TABLE 160. GLOBAL BIODEFENSE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
  • TABLE 161. GLOBAL BIODEFENSE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
  • TABLE 162. GLOBAL BIODEFENSE MARKET RANKING, BY KEY PLAYER, 2022
  • TABLE 163. GLOBAL BIODEFENSE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 164. GLOBAL BIODEFENSE MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
  • TABLE 165. GLOBAL BIODEFENSE MARKET MERGER & ACQUISITION
  • TABLE 166. GLOBAL BIODEFENSE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 167. GLOBAL BIODEFENSE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 168. GLOBAL BIODEFENSE MARKET INVESTMENT & FUNDING
  • TABLE 169. GLOBAL BIODEFENSE MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 170. GLOBAL BIODEFENSE MARKET: LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!